Perbandingan Tingkat Deteksi Bakteri Gram Negatif Penghasil Karbapenemase Pada Uji Carba Nordmann Poirel (Carba NP) Dan Modified Hodge Test (MHT)

Mulat Muliasih, Andaru Dahesihdewi, Umi Solekhah Intansari

Sari


Penggunaan karbapenem yang tinggi pada infeksi bakteri Gram negatif menimbulkan resistansi dengan mekanisme terbanyak berupa produksi enzim karbapenemase yang menyebabkan kematian lebih tinggi daripada mekanisme lain. Diperlukan suatu uji fenotip pendeteksi penghasil karbapenemase yang bisa menentukan terapi dengan cepat dan mengontrol penyebaran infeksi. Penelitian ini merupakan penelitian observasional analitik dengan rancangan potong lintang. Sampel berupa isolat klinis pasien bangsal dengan hasil tes kultur berupa patogen Gram negatif resistan karbapenem. Kriteria eksklusi yaitu sampel klinis berasal dari alat, hasil kultur polimikrobia, dan data rekam medis tidak lengkap. Isolat klinis diperiksa uji Carba NP dan MHT untuk dideteksi sebagai penghasil karbapenemase. Kemampuan kedua uji dibandingkan dan dihitung nilai Kappa. Hasil penelitian Carba NP mendeteksi karbapenemase 56 isolat (74,66%), tidak berbeda bermakna dengan uji MHT yang mendeteksi 53 isolat (70,66%), p 0,549. Nilai Kappa kedua metode 0,6.


Kata Kunci


Bakteri Gram Negatif; Carba NP; MHT; Penghasil Karbapenemase; Resistan Karbapenem

Teks Lengkap:

PDF

Referensi


Bennett, J. W., Herrera, M. L., Lewis II, J. S., Wickes, B. W., Jorgensen, J. H. (2009). KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient. Antimicrob. Agents Chemother. 53(1):292–294.

Bialvaei, A. Z. (2016). Current Methods for The Identification Of Carbapenemases Current Methods for The Identification Of Carbapenemases. J Chemoter. 28: 1-19.

Bush, K & Fisher, J. F. (2011). Epidemiological Expansion, Structural Studies, and Clinical Challenges of New β-Lactamases from Gram-Negative Bacteria. Annu. Rev. Microbiol. 65(1): 455–478.

CLSI. (2019). Performance Standards for Antimicrobial Susceptibility Testing M100. 29th ed. Clinical and Laboratory Standards Institute, Wayne.

Datta, S, Dey, R, Dey, J.B & Gosh, S. (2017). A Comparative Study of Modified Hodge Test and Carba NP Test for Detecting Carbapenemase Production in Gram Negative Bacteria. Med. J. DY Patil Vidyapeeth. 10(4): 365.

Dortet, L., Poirel, L., Nordmann, P. (2012). Rapid Detection of Carbapenemase Producing Pseudomonas spp. J. Clin. Microbiol. 50(11): 3773–3776.

Gauthier, L., Bonnin, R.A., Dortet, L., Naas, T. (2017). Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae. PLoS ONE: 1–12.

Girlich, D, Poirel, L & Nordmann, P. (2012). Value of The Modified Hodge Test for Detection of Emerging Carbapenemases in Enterobacteriaceae. J. Clin. Microb. 50(2): 477–479.

Ivanova, K. (2018). Carbapenemase Types and Detection. Probl. Inf. Parasit. Dis, 42(2).

Kuntaman, K, Shigemura, K, Osawa, K, Kitagawa, K, Sato, K, Yamada, N, Nishimoto, K, Yamamichi, F, Rahardjo, D, Hadi, U, Mertaniasih, N. M, Kinoshita, S, Fujisawa, M & Shirakawa, T. (2018). Occurrence and Characterization of Carbapenem-Resistant Gram-Negative Bacilli : A Collaborative Study of Antibiotic-Resistant Bacteria between Indonesia and Japan. Int. J. Urol. 25: 966-972.

Lutgring, J. D & Limbago, B. M. (2016). The Problem of Carbapenemase-Producing Carbapenem-Resistant-Enterobacteriaceae Detection. J. Clin. Microb. 54(3): 529–534.

Nordmann, P & Poirel, L. (2019). Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clin. Infect. Dis. 69: Suppl 7: S521–S528.

Pasteran, F, Tijet, N, Melano, R. G, Corso, A. (2015). Simplified Protocol for Carba NP Test for Enhanced Detection of Carbapenemase Producers Directly from Bacterial Cultures. J. Clin. Microb. 53(12): 3908–3911.

Queenan, A. M & Bush, K. (2007). Carbapenemases : the Versatile β-Lactamases. Clin. Microbiol. Rev. 20(3): 440–458.

Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA & Alqumber MAA. (2023). Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare. 11(13):1946.

Shanthi, M. Sekar, U., Arunagiri, K., Hemant, G. B. (2013). OXA-181 beta lactamase is not a major mediator of carbapenem resistance in Enterobacteriaceae. J. Clin. Diagn. Res. 7(9) : 1986–1988.

Shinde, S, Gupta, R, Raut, S. S, Nataraj, G & Mehta, P. R. (2017). Carba NP as a Simpler, Rapid, Cost-Effective, and a More Sensitive Alternative to Other Phenotypic Tests for Detection of Carbapenem Resistance in Routine Diagnostic Laboratories. J Lab Physicians. 9(2): 100.

Simner, P. J, Johnson, K, Brasso, W. B, Anderson, K, Lonsway, D.R, Pierce, V.M, Bobenchik, A.M, Lockett, Z.C, Charnot-Katsikas, A, Westblade, L.F, Yoo, B.B, Jenkins, S.G, Limbago, B.M, Das, S & Roe-Carpenter, D.E. (2018). Multicenter Evaluation of The Modified Carbapenem Inactivation Method and The Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii. J. Clin. Microb. 56(1): 1–10.

Sutandhio, S, Budiono, Hardiono, Kuntaman, Wasito, E. B & Lusida, M. I. (2018). Comparation of Phenotypic and Genotypic Profile of Carbapenemase Producing Escherichia coli. Folia Med. 54(1): 10.

Tamma, P. D & Simner, P. J. (2017). Comparing The Outcomes of Patients with Carbapenemase-producing and Non-carbapenemase-producing Carbapenem Resistant Enterobacteriaceae Bacteremia. Clin. Infect. Dis. 64(3): 257–264.

Tamma, P. D & Simner, J. (2018). Phenotypic Detection of Carbapenemase-producing Organisms from Clinical Isolates. J. Clin. Microb. 56(11): 1–13.

Vasoo, S, Barreto, J. N & Tosh, P. K. (2015). Emerging Issues in Gram-Negative Bacterial Resistance: An Update for the Practicing Clinician. Mayo Clinic Proceedings. Elsevier Inc, 90(3): 395–403.




DOI: https://doi.org/10.33024/jikk.v11i12.17485

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

Pendidikan Dokter Universitas Malahayati Lampung



Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.